1. Percutaneous valve in valve in the tricuspid position in a patient with Tetralogy of Fallot
- Author
-
Ryan Markham, A. Challa, and Darren L. Walters
- Subjects
Adult ,medicine.medical_specialty ,Percutaneous ,Heart disease ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Valve replacement ,medicine ,Humans ,030212 general & internal medicine ,Novel Treatment (New Drug/Intervention ,Established Drug/Procedure in New Situation) ,Tetralogy of Fallot ,Heart Valve Prosthesis Implantation ,Tricuspid valve ,Interventional cardiology ,business.industry ,General Medicine ,medicine.disease ,Surgery ,Position (obstetrics) ,medicine.anatomical_structure ,Heart failure ,Female ,Tricuspid Valve ,business ,Angioplasty, Balloon - Abstract
Here, we describe a case of a successful percutaneous insertion of a transcatheter 29 mm Edwards Sapien XT valve into a tricuspid valve in a patient with repaired tetralogy of fallot. Similar procedures have been performed with the Edwards Sapien valve and Melody valves; however, this is the first case described in the literature of an Edwards Sapien valve used in a patient with Tetralogy of Fallot. With procedural safety being demonstrated, this case illustrates an important alternative treatment option for patients with congenital heart disease. Although long-term data is required to compare its efficacy with surgically replaced valves, percutaneous procedures can serve as a delay to surgical valve replacement which over a patients’ lifetime with congenital heart disease, can minimise the amount of invasive surgeries and potential complications.
- Published
- 2017